8-K: Current report filing
Published on January 3, 2008
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of
Report (date of earliest event reported): January 3,
2008 (January 3, 2008)
Rexahn
Pharmaceuticals, Inc.
(Exact
name of registrant as specified in its charter)
|
Delaware
|
000-50590
|
11-3516358
|
|
(State
or Other Jurisdiction of
Incorporation)
|
(CommissionFile
Number)
|
(I.R.S.
EmployerIdentification
No.)
|
9620
Medical Center Drive
Rockville,
Maryland 20850
(Address
of principal executive offices) (Zip code)
(240)
268-5300
(Registrant's
telephone number, including area code)
Not
Applicable
(Former
name or former address, if changed since last report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
¨ Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
¨ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
¨ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
¨ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
INFORMATION
TO BE INCLUDED IN THE REPORT
Item
8.01. Other Events.
As
previously reported, Rexahn Pharmaceuticals, Inc. has completed a private
sale
of shares of its common stock. A copy of the Company’s press release
making this announcement is attached as Exhibit 99.1 and incorporated by
reference into this Item 8.01.
Item
9.01. Financial Statements and Exhibits.
(d)
Exhibits.
|
Exhibit
Number
|
Description
|
|
|
99.1
|
Press
Release dated January 3, 2008.
|
2
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
REXAHN
PHARMACEUTICALS, INC.
|
||
|
(Registrant)
|
||
|
By
|
/s/
Chang H. Ahn
|
|
|
Chang
H. Ahn
|
||
|
Chairman
and Chief Executive Officer
|
||
Date:
January 3, 2008
3
EXHIBIT
INDEX
|
Exhibit
Number
|
Description
|
|
|
Press
Release dated January 3,
2008.
|
4